Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age
Background: Neonatal antibiotics disturb the developing gut microbiome and are therefore thought to influence the developing immune system, but exact mechanisms and health consequences in later life still need to be elucidated. Therefore, we investigated whether neonatal antibiotics influence inflam...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02939/full |
id |
doaj-abb5da3fd8494051a817e9d9a10c864e |
---|---|
record_format |
Article |
spelling |
doaj-abb5da3fd8494051a817e9d9a10c864e2020-11-25T01:29:34ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-01-011010.3389/fimmu.2019.02939484087Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of AgeBerthe C. Oosterloo0Belinda van't Land1Belinda van't Land2Wilco de Jager3Nicole B. Rutten4Margot Klöpping5Johan Garssen6Johan Garssen7Arine M. Vlieger8Ruurd M. van Elburg9Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsCenter for Translational Immunology, University Medical Centre Utrecht, Utrecht, NetherlandsDanone Nutricia Research, Utrecht, NetherlandsCenter for Translational Immunology, University Medical Centre Utrecht, Utrecht, NetherlandsSt. Antonius Hospital, Department of Pediatrics, Nieuwegein, NetherlandsCenter for Translational Immunology, University Medical Centre Utrecht, Utrecht, NetherlandsDanone Nutricia Research, Utrecht, NetherlandsUtrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, NetherlandsSt. Antonius Hospital, Department of Pediatrics, Nieuwegein, NetherlandsDepartment of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsBackground: Neonatal antibiotics disturb the developing gut microbiome and are therefore thought to influence the developing immune system, but exact mechanisms and health consequences in later life still need to be elucidated. Therefore, we investigated whether neonatal antibiotics influence inflammatory markers at 1 year of age. In addition, we determined whether health problems during the first year of life, e.g., allergic disorders (eczema and wheezing) or infantile colics, were associated with changes in the circulating immune marker profile at 1 year of age.Methods: In a subgroup (N = 149) of the INCA-study, a prospective birth-cohort study, a blood sample was drawn from term born infants at 1 year of age and analyzed for 84 immune related markers using Luminex. Associations of antibiotic treatment, eczema, wheezing, and infantile colics with immune marker concentrations were investigated using a linear regression model. The trial is registered as NCT02536560.Results: The use of broad-spectrum antibiotics in the first week of life, was significantly associated with different levels of inflammatory markers including sVCAM-1, sCD14, sCD19, sCD27, IL-1RII, sVEGF-R1, and HSP70 at 1 year of age. Eczema was associated with decreased concentrations of IFNα, IFNγ, TSLP, CXCL9, and CXCL13, but increased concentrations of CCL18 and Galectin-3. Wheezing, independent of antibiotic treatment, was positively associated to TNF-R2 and resistin. Infantile colics were positively associated to IL-31, LIGHT, YKL-40, CXCL13, sPD1, IL1RI, sIL-7Ra, Gal-1, Gal-9, and S100A8 at 1 year of age, independent of early life antibiotic treatment.Conclusion: In this explorative study, we identified that neonatal antibiotics are associated with immunological alterations at 1 year of age and that, independent of the antibiotic treatment, infantile colics were associated with alterations within gut associated markers. These findings support the importance of the first host microbe interaction in early life immune development.https://www.frontiersin.org/article/10.3389/fimmu.2019.02939/fullbiomarkersimmune developmentinfantantibioticsinfantile coliceczema |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Berthe C. Oosterloo Belinda van't Land Belinda van't Land Wilco de Jager Nicole B. Rutten Margot Klöpping Johan Garssen Johan Garssen Arine M. Vlieger Ruurd M. van Elburg |
spellingShingle |
Berthe C. Oosterloo Belinda van't Land Belinda van't Land Wilco de Jager Nicole B. Rutten Margot Klöpping Johan Garssen Johan Garssen Arine M. Vlieger Ruurd M. van Elburg Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age Frontiers in Immunology biomarkers immune development infant antibiotics infantile colic eczema |
author_facet |
Berthe C. Oosterloo Belinda van't Land Belinda van't Land Wilco de Jager Nicole B. Rutten Margot Klöpping Johan Garssen Johan Garssen Arine M. Vlieger Ruurd M. van Elburg |
author_sort |
Berthe C. Oosterloo |
title |
Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age |
title_short |
Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age |
title_full |
Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age |
title_fullStr |
Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age |
title_full_unstemmed |
Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age |
title_sort |
neonatal antibiotic treatment is associated with an altered circulating immune marker profile at 1 year of age |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2020-01-01 |
description |
Background: Neonatal antibiotics disturb the developing gut microbiome and are therefore thought to influence the developing immune system, but exact mechanisms and health consequences in later life still need to be elucidated. Therefore, we investigated whether neonatal antibiotics influence inflammatory markers at 1 year of age. In addition, we determined whether health problems during the first year of life, e.g., allergic disorders (eczema and wheezing) or infantile colics, were associated with changes in the circulating immune marker profile at 1 year of age.Methods: In a subgroup (N = 149) of the INCA-study, a prospective birth-cohort study, a blood sample was drawn from term born infants at 1 year of age and analyzed for 84 immune related markers using Luminex. Associations of antibiotic treatment, eczema, wheezing, and infantile colics with immune marker concentrations were investigated using a linear regression model. The trial is registered as NCT02536560.Results: The use of broad-spectrum antibiotics in the first week of life, was significantly associated with different levels of inflammatory markers including sVCAM-1, sCD14, sCD19, sCD27, IL-1RII, sVEGF-R1, and HSP70 at 1 year of age. Eczema was associated with decreased concentrations of IFNα, IFNγ, TSLP, CXCL9, and CXCL13, but increased concentrations of CCL18 and Galectin-3. Wheezing, independent of antibiotic treatment, was positively associated to TNF-R2 and resistin. Infantile colics were positively associated to IL-31, LIGHT, YKL-40, CXCL13, sPD1, IL1RI, sIL-7Ra, Gal-1, Gal-9, and S100A8 at 1 year of age, independent of early life antibiotic treatment.Conclusion: In this explorative study, we identified that neonatal antibiotics are associated with immunological alterations at 1 year of age and that, independent of the antibiotic treatment, infantile colics were associated with alterations within gut associated markers. These findings support the importance of the first host microbe interaction in early life immune development. |
topic |
biomarkers immune development infant antibiotics infantile colic eczema |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2019.02939/full |
work_keys_str_mv |
AT berthecoosterloo neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage AT belindavantland neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage AT belindavantland neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage AT wilcodejager neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage AT nicolebrutten neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage AT margotklopping neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage AT johangarssen neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage AT johangarssen neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage AT arinemvlieger neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage AT ruurdmvanelburg neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage |
_version_ |
1725096322225143808 |